| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |